Mount Sinai Health System prioritizes the value of AI beyond just financial gain, with a unique leadership structure and focus on ethical implementation.
During the third quarter of fiscal year 2025 (“Q3 FY2025”) and to date in 2025, HeartSciences has seen material progress towards FDA submissions of our products and there have been significant ...
As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in ...
HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused ...
In response, Cogito Tech has launched DataSum, a certification framework designed to make AI data sourcing more transparent ...
As healthcare organizations seek to improve efficiency and accuracy in medical coding, many are exploring AI-driven solutions ...
The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.
CORRECTION: Canaccord Genuity was involved in the placement of only a portion, not all, of the 14 million shares ...
About the Mount Sinai Global Surgery Program The Mount Sinai ... audiovisual capabilities, AI, and machine learning to elevate patient safety, optimize operations, and facilitate continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback